Advertisement

Charcoal Hemoperfusion: Georgetown University Hospital Experience

  • Michael C. Gelfand

Abstract

At Georgetown University Hospital, interest in charcoal hemoperfusion as a means of facilitating toxin removal from blood has shown a doubled peaked history. After the pioneering work of Yatzidis, et al (1) in 1965 in the treatment of barbiturate poisoning, DeMyttenaere, Maher, and Schreiner in 1967 demonstrated the effectiveness of charcoal hemoperfusion in the treatment of glutethimide overdosage in dogs (2). Unfortunately, because of the significant and potentially life threatening dangers of thrombocytopenia and charcoal embolization, charcoal hemoperfusion was not pursued as an attractive therapeutic modality for toxin removal in clinical practice.

Keywords

Drug Overdosage Fulminant Hepatic Failure Hepatic Coma Blood Ammonia Level Chronic Aggressive Hepatitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Yatzidis, H., Oreopoulos, D., and Triantaphyllidis, D. Treatment of seven barbiturate poisonings. Lancet 1:216–217, 1965.PubMedCrossRefGoogle Scholar
  2. 2.
    DeMyttenaere, M.M., Maher, J.F., Schreiner, G.E. Hemoperfu-sion through a charcoal column for glutethimide poisoning. Trans Am Soc Artif Int Organs, 13:190, 1967.Google Scholar
  3. 3.
    Fennimore, J. and Munro, G.D. Design and development of the Smith and Nephew Column. 1, Proceedings of an International Symposium on Artificial Support Systems for Acute Hepatic Failure, 330, 1974.Google Scholar
  4. 4.
    Winchester, J.F. Evaluation of charcoal hemoperfusion in uremia (In press).Google Scholar
  5. 5.
    Gelfand, M.C., Knepshïeld, J.H., Cohan, S., Ramirez, B., and Schreiner, G.E. Treatment of hepatic coma with hemoperfusion through Polyacrylamide hydrogel coated charcoal. Kidney Int 10:S239, 1076.Google Scholar
  6. 6.
    Arieff, A.I, and Friedman, E.A. Coma following non-narcotic drug overdosage. Management of 208 adult patients. Am J Med Sci 266:405–426, 1973.PubMedCrossRefGoogle Scholar
  7. 7.
    Carvallo, A., Ramirez, B., Honig, H., Knepshïeld, J.H., Schreiner, G.E., and Gelfand, M.C. Treatment of digitalis intoxication by charcoal hemoperfusion (CHP). Tran Am Soc Artif Int Organs 22:718–722, 1976.Google Scholar
  8. 8.
    Gazzard, B.G., Portmann, B.A., Weston, M.J., Langley, P.G., Murray-Lyon, I.M., Dunlop, E.H., Flax, H., Mellon, P.J., Record, CO., Ward, M.B., Williams, R. Charcoal hemoperfusion in the treatment of fulminant hepatic failure. Lancet 1:1301–1307, 1974.PubMedCrossRefGoogle Scholar
  9. 9.
    Chang, T.M.S. Haemoperfusions over microencapsulated adsorbent in a patient with hepatic coma. Lancet 2:1371–1372, 1972PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1978

Authors and Affiliations

  • Michael C. Gelfand
    • 1
  1. 1.Nephrology DivisionGeorgetown University HospitalUSA

Personalised recommendations